Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study Into the Mechanism of Mirabegron-induced Cardiovascular Effects in Healthy Male Subjects.

NCT01284868 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01284868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01284868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study Into the Mechanism of Mirabegron-induced Cardiovascular Effects in Healthy Male Subjects.
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2009
Completion date
November 30, 2009
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, pharmacodynamics of mirabegron